Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q2)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q2)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 1,589.50%283.06K | 2,535.75%141.65K | 2,535.75%141.65K | 301.10%16.75K | 66.89%5.37K | 66.89%5.37K | --4.18K | -74.22%3.22K | -74.22%3.22K | ---- |
-Cash and cash equivalents | 1,589.50%283.06K | 2,535.75%141.65K | 2,535.75%141.65K | 301.10%16.75K | 66.89%5.37K | 66.89%5.37K | --4.18K | -74.22%3.22K | -74.22%3.22K | ---- |
Receivables | 558.46%1.04M | 226.05%520.74K | 226.05%520.74K | -19.09%158.63K | -19.59%159.71K | -19.59%159.71K | -3.56%196.04K | -68.05%198.62K | -68.05%198.62K | -19.29%203.27K |
Other assets | 1.98%15.11K | -8.09%18.85K | -8.09%18.85K | -3.65%14.82K | 1.48%20.5K | 1.48%20.5K | -12.67%15.38K | -18.50%20.2K | -18.50%20.2K | -3.23%17.61K |
Total assets | 15.63%84.66M | 14.82%79.13M | 14.82%79.13M | 8.06%73.22M | -27.22%68.91M | -27.22%68.91M | -29.28%67.76M | 2.33%94.68M | 2.33%94.68M | -32.16%95.81M |
Liabilities | ||||||||||
Payables | 45.74%123.24K | 16.27%93.22K | 16.27%93.22K | 20.93%84.56K | -93.37%80.18K | -93.37%80.18K | -17.76%69.93K | 71.81%1.21M | 71.81%1.21M | -59.36%85.03K |
-Accounts payable | 459.76%116.86K | 23.53%22.46K | 23.53%22.46K | -66.47%20.88K | -98.49%18.18K | -98.49%18.18K | -21.38%62.26K | 72.48%1.2M | 72.48%1.2M | -60.98%79.19K |
-Other payable | -89.98%6.38K | 14.14%70.77K | 14.14%70.77K | 730.85%63.69K | 875.61%62K | 875.61%62K | 31.29%7.67K | -1.41%6.36K | -1.41%6.36K | -6.61%5.84K |
Long term debt and capital lease obligation | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | -50.00%4M | -50.00%4M | -50.00%4M |
Total liabilities | 14.43%4.85M | 7.79%4.55M | 7.79%4.55M | 1.92%4.24M | -20.16%4.22M | -20.16%4.22M | 0.46%4.16M | -39.74%5.29M | -39.74%5.29M | -49.91%4.14M |
Shareholders'equity | ||||||||||
Share capital | 0.87%56.15M | 0.87%56.15M | 0.87%56.15M | 0.50%55.67M | 0.50%55.67M | 0.50%55.67M | 17.24%55.39M | 17.24%55.39M | 17.24%55.39M | -60.08%47.25M |
-common stock | 0.87%56.15M | 0.87%56.15M | 0.87%56.15M | 0.50%55.67M | 0.50%55.67M | 0.50%55.67M | 17.24%55.39M | 17.24%55.39M | 17.24%55.39M | -60.08%47.25M |
Retained earnings | 77.73%23.65M | 104.23%18.42M | 104.23%18.42M | 62.16%13.31M | -73.47%9.02M | -73.47%9.02M | -81.53%8.21M | -6.85%34M | -6.85%34M | 203.63%44.43M |
Total stockholders'equity | 15.70%79.81M | 15.28%74.58M | 15.28%74.58M | 8.46%68.98M | -27.63%64.69M | -27.63%64.69M | -30.63%63.6M | 6.74%89.39M | 6.74%89.39M | -31.06%91.68M |
Total equity | 15.70%79.81M | 15.28%74.58M | 15.28%74.58M | 8.46%68.98M | -27.63%64.69M | -27.63%64.69M | -30.63%63.6M | 6.74%89.39M | 6.74%89.39M | -31.06%91.68M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |